121 related articles for article (PubMed ID: 31233480)
1. Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.
Victor DW; Monsour HP; Boktour M; Lunsford K; Balogh J; Graviss EA; Nguyen DT; McFadden R; Divatia MK; Heyne K; Ankoma-Sey V; Egwim C; Galati J; Duchini A; Saharia A; Mobley C; Gaber AO; Ghobrial RM
Transplantation; 2020 Jan; 104(1):113-121. PubMed ID: 31233480
[TBL] [Abstract][Full Text] [Related]
2. Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies.
Lei J; Yan L
J Gastrointest Surg; 2013 Jun; 17(6):1116-22. PubMed ID: 23325342
[TBL] [Abstract][Full Text] [Related]
3. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies.
Lei J; Yan L
J Gastrointest Surg; 2012 Nov; 16(11):2120-5. PubMed ID: 22948843
[TBL] [Abstract][Full Text] [Related]
4. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?
Koniaris LG; Levi DM; Pedroso FE; Franceschi D; Tzakis AG; Santamaria-Barria JA; Tang J; Anderson M; Misra S; Solomon NL; Jin X; DiPasco PJ; Byrne MM; Zimmers TA
Ann Surg; 2011 Sep; 254(3):527-37; discussion 537-8. PubMed ID: 21865950
[TBL] [Abstract][Full Text] [Related]
5. Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American Experience.
Ivanics T; Claasen MPAW; Samstein B; Emond JC; Fox AN; Pomfret E; Pomposelli J; Tabrizian P; Florman SS; Mehta N; Roberts JP; Emamaullee JA; Genyk Y; Hernandez-Alejandro R; Tomiyama K; Sasaki K; Hashimoto K; Nagai S; Abouljoud M; Olthoff KM; Hoteit MA; Heimbach J; Taner T; Liapakis AH; Mulligan DC; Sapisochin G; Halazun KJ;
Ann Surg; 2024 Jan; 279(1):104-111. PubMed ID: 37522174
[TBL] [Abstract][Full Text] [Related]
6. Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation.
Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Yu YD; Park PJ; Choi YI; Kim KW; Lim YS; Lee HC; Yu ES; Lee SG
J Gastrointest Surg; 2011 Jun; 15(6):971-81. PubMed ID: 21547706
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.
Xu DW; Wan P; Xia Q
World J Gastroenterol; 2016 Mar; 22(12):3325-34. PubMed ID: 27022214
[TBL] [Abstract][Full Text] [Related]
8. Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice.
Zhang XF; Xue F; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
J Gastrointest Surg; 2022 May; 26(5):1021-1029. PubMed ID: 34797558
[TBL] [Abstract][Full Text] [Related]
9. Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria.
Lei J; Wang W; Yan L
J Gastrointest Surg; 2013 Aug; 17(8):1440-6. PubMed ID: 23719776
[TBL] [Abstract][Full Text] [Related]
10. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis.
Arvind A; Seif El Dahan K; Malhotra R; Daher D; Rich NE; Patel MS; VanWagner LB; Lieber SR; Cotter TG; Louissaint J; Mufti AR; Kulik L; Pillai A; Parikh ND; Singal AG
Liver Transpl; 2024 Jun; 30(6):595-606. PubMed ID: 38466889
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.
Akateh C; Black SM; Conteh L; Miller ED; Noonan A; Elliott E; Pawlik TM; Tsung A; Cloyd JM
World J Gastroenterol; 2019 Jul; 25(28):3704-3721. PubMed ID: 31391767
[TBL] [Abstract][Full Text] [Related]
12. Effect of Locoregional Treatments in Hepatocellular Carcinoma: What Are the Pathologic/Radiologic Milan Criteria?
Aksoy F; Dundar HZ; Celik F; Ongen G; Nas OF; Saglam K; Gurluer E; Kıyıcı M; Kaya E
Exp Clin Transplant; 2023 Oct; 21(10):820-825. PubMed ID: 37965957
[TBL] [Abstract][Full Text] [Related]
13. Expanding the Boundaries for Liver Transplantation for Hepatocellular Carcinoma.
Lindemann J; Doyle MBM
Surg Clin North Am; 2024 Feb; 104(1):129-143. PubMed ID: 37953032
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?
Pahari H; Raj A; Sawant A; Ahire DS; Rathod R; Rathi C; Sankalecha T; Palnitkar S; Raut V
World J Transplant; 2024 Mar; 14(1):88833. PubMed ID: 38576752
[TBL] [Abstract][Full Text] [Related]
15. A mathematical model for optimizing the indications of liver transplantation in patients with hepatocellular carcinoma.
Chaib E; Amaku M; Coutinho FA; Lopez LF; Burattini MN; D'Albuquerque LA; Massad E
Theor Biol Med Model; 2013 Oct; 10():60. PubMed ID: 24139285
[TBL] [Abstract][Full Text] [Related]
16. Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma.
Urquijo-Ponce JJ; Alventosa-Mateu C; Latorre-Sánchez M; Castelló-Miralles I; Diago M
World J Gastroenterol; 2024 May; 30(19):2512-2522. PubMed ID: 38817666
[TBL] [Abstract][Full Text] [Related]
17. Bridging locoregional treatment prior to liver transplantation for cirrhotic patients with hepatocellular carcinoma within the Milan criteria: a systematic review and meta-analysis.
Kostakis ID; Dimitrokallis N; Iype S
Ann Gastroenterol; 2023; 36(4):449-458. PubMed ID: 37396004
[TBL] [Abstract][Full Text] [Related]
18. New horizons in liver transplantation for hepatocellular carcinoma.
Lindemann J; Yu J; Doyle MMB
S Afr J Surg; 2024 May; 62(2):8-12. PubMed ID: 38838112
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Vogel A; Cervantes A; Chau I; Daniele B; Llovet JM; Meyer T; Nault JC; Neumann U; Ricke J; Sangro B; Schirmacher P; Verslype C; Zech CJ; Arnold D; Martinelli E;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv238-iv255. PubMed ID: 30285213
[No Abstract] [Full Text] [Related]
20. Expanding Selection Criteria in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma: Long-term Follow-up of a National Registry and 2 Transplant Centers.
Wehrle CJ; Kusakabe J; Akabane M; Maspero M; Zervos B; Modaresi Esfeh J; Whitsett Linganna M; Imaoka Y; Khalil M; Pita A; Kim J; Diago-Uso T; Fujiki M; Eghtesad B; Quintini C; Kwon CD; Pinna A; Aucejo F; Miller C; Mazzaferro V; Schlegel A; Sasaki K; Hashimoto K
Transplantation; 2024 Jun; ():. PubMed ID: 38831488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
